Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
What does new drug PaMZ mean for TB and HIV treatment?

The development of PaMZ has been hailed as a breakthrough. But what do the experts think?

Published
1 hour ago
From
The Guardian
Acquired rifampicin resistance more likely in HIV-coinfected patients

Patients with HIV and tuberculosis were more likely to develop acquired rifampicin resistance when treated with a thrice-weekly tuberculosis treatment compared with patients not coinfected with HIV, according to researchers from the National Institute for Research in Tuberculosis in India. The rate of bacteriologic failure was 4% among patients without HIV. Among patients with HIV, the rates were 9% for those not receiving ART and 5% for those receiving ART.

Published
2 hours ago
From
Healio
TB Epidemic Threat Hangs Over Ukraine Conflict

Doctors are warning of a worsening tuberculosis epidemic in Eastern Ukraine as the continuing conflict there begins to take a heavy toll on public health. With thousands of people fleeing the region every day, medical supplies severely disrupted and those left behind under growing physical stress and increasingly unable to access medical services, conditions are ripe for a rise in new TB cases.

Published
20 August 2014
From
InterPress Service
Use of drug susceptibility testing to select therapy improves treatment outcomes in patients with MDR- and XDR-TB

New research published in the online edition of Clinical Infectious Diseases supports World Health Organization (WHO) recommendations for the use of drug susceptibility testing to select drugs for the

Published
13 August 2014
By
Michael Carter
Study in South African township shows HIV-negative individuals often source of new TB cases in patients with HIV

HIV-negative individuals are an important source of new tuberculosis (TB) cases in people living with HIV, according to a study conducted in a South African township

Published
11 August 2014
By
Michael Carter
Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test

Decentralisation of drug-resistant tuberculosis (DR-TB) management and use of the Xpert MTB/RIF test improves the time from clinic presentation to treatment from 50 days to 7 days

Published
23 July 2014
By
Lesley Odendal
From Rhetoric to Reality: An Analysis of Efforts to Scale Up The Response to TB-HIV

A new research report from ACTION global health shows that joint TB-HIV activities are neglected by HIV programs and overwhelmingly carried out by TB programs, and that global guidelines to address TB-HIV have not been prioritized by leading donors and affected countries.

Published
22 July 2014
From
ACTION
Novel TB regimen could reduce treatment duration

A novel TB drug regimen that could treat drug-sensitive and some forms of drug-resistant TB far more quickly than current standard TB therapy, according to findings from a

Published
21 July 2014
By
Lesley Odendal
HIV, HCV and TB Pipeline Report

Drugs, diagnostics, vaccines, preventive technologies, research towards a cure, and immune-based and gene therapies in development.

Published
21 July 2014
From
Treatment Action Group & i-Base
U.K. Omitted From Plan to Eliminate TB in Rich Countries

The U.K. has too big a problem with tuberculosis to participate in a World Health Organization plan to eliminate the world’s second-deadliest disease from more than 30 countries.

Published
04 July 2014
From
Bloomberg
← First12345...84Next →

Filter by country